NCT07552220

Brief Summary

Myositis is an inflammatory disease of the skeletal muscles that can be caused by infections, autoimmune diseases, or medications. Early diagnosis of these conditions is essential for optimal treatment. Anatomic pathology is the conventional method used to analyze muscle lesions, but it requires several weeks to obtain results. Full-field optical coherence tomography (OCT), a non-invasive imaging technique, could offer advantages in terms of speed and resolution for visualizing muscle inflammation. This research project compares histological pathology and full-field OCT for the analysis of muscle biopsies from healthy individuals and patients suspected of having myositis. The aim of this study is to establish an OCT reference standard by analyzing control muscle biopsies and then comparing muscle inflammation in confirmed cases of myositis. The advantages and limitations of both methods will also be evaluated.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
32mo left

Started Apr 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Apr 2026Dec 2028

Study Start

First participant enrolled

April 1, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 3, 2026

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 27, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 3, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

anatomopathologyFull field optical coherence tomographymuscle biopsiesMyositis and healthy patients

Outcome Measures

Primary Outcomes (2)

  • Evaluation of the spatial resolution of the two methods

    Image acquisitions will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness. To obtain structural tissue data, OCT acquisitions will be performed in full field mode (FF-OCT), and Hematoxylin-Eosin, Gomori's trichrome and NADH staining will be carried out on histological sections. For each method, the criteria evaluated will be the ability to detect fiber structure, the presence of fibrosis and blood vessels. Image comparison will be performed by specialized pathologists and then by an autoML type artificial intelligence, with assessment of accuracy and recall.

    2 years

  • Evaluation of inflammation detection of the two methods

    Image acquisition will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness. OCT acquisitions will be carried out in dynamic colorimetric mode (DCI) to observe the intensity and variability of metabolic activity across the entire fresh tissue sample using a color panel ranging from blue to red. Inflammation detection on histological sections will be observed using the markers HLA1, HLA-DR, C5B9, P62, CD31, CD56. The potential correlation between metabolic activity and inflammation will be visually assessed by specialized pathologists and by an autoML type artificial intelligence with assessment of accuracy and recall.

    2 years

Secondary Outcomes (1)

  • Establish the advantages and limitations of the two methods

    2 years

Study Arms (2)

Healthy patients

Muscle biopsies collected during orthopedic surgery (performed as part of care)

Myositis patients

Muscle biopsies collected as part of care to establish a diagnosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Myositis or healthy major patients

You may qualify if:

  • Patient \> 18 years old ans has given his oral consent
  • Patient who biospies are performed as part of care

You may not qualify if:

  • Patient \< 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de Mâcon

Mâcon, 71000, France

Location

Biospecimen

Retention: SAMPLES WITH DNA

Frozen muscle biopsies

MeSH Terms

Conditions

Myositis

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System Diseases

Central Study Contacts

Thibault Maillet, Doctor

CONTACT

Emilie Chopin, Biology master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 3, 2026

First Posted

April 27, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

April 27, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations